Melatonin in Neurodevelopmental Disorders: A Critical Literature Review

Antioxidants (Basel). 2023 Nov 20;12(11):2017. doi: 10.3390/antiox12112017.

Abstract

The article presents a review of the relationships between melatonin and neurodevelopmental disorders. First, the antioxidant properties of melatonin and its physiological effects are considered to understand better the role of melatonin in typical and atypical neurodevelopment. Then, several neurodevelopmental disorders occurring during infancy, such as autism spectrum disorder or neurogenetic disorders associated with autism (including Smith-Magenis syndrome, Angelman syndrome, Rett's syndrome, Tuberous sclerosis, or Williams-Beuren syndrome) and neurodevelopmental disorders occurring later in adulthood like bipolar disorder and schizophrenia, are discussed with regard to impaired melatonin production and circadian rhythms, in particular, sleep-wake rhythms. This article addresses the issue of overlapping symptoms that are commonly observed within these different mental conditions and debates the role of abnormal melatonin production and altered circadian rhythms in the pathophysiology and behavioral expression of these neurodevelopmental disorders.

Keywords: autism; brain development; circadian rhythms; melatonin; neurodevelopmental disorders; schizophrenia; sleep disturbance; sleep–wake rhythms.

Publication types

  • Review

Grants and funding

This research received no external funding.